Oct 07, 2021 / Presentations

Data on Medicare’s net prices for prescription drugs and other drug pricing metrics

Research Areas:

Drugs, Devices, and Tests

Sep 02, 2021 / Presentations

Mandated report: Impact of Bipartisan Budget Act 2018 changes to the home health prospective payment system

Research Areas:

Post-Acute Care

Sep 02, 2021 / Presentations

Mandated report: Designing a value incentive program for post-acute care

Research Areas:

Delivery System Reforms, Post-Acute Care

Sep 02, 2021 / Presentations

Potential reforms to Part D’s low-income premium subsidy

Research Areas:

Drugs, Devices, and Tests, Private Plans

Sep 02, 2021 / Presentations

Effects of the coronavirus public health emergency and considerations for MedPAC’s 2022 assessment of Medicare payment adequacy

Research Areas:

Ambulatory Care Settings, Hospitals, Physicians And Other Health Professionals, Post-Acute Care

Sep 02, 2021 / Presentations

Context for Medicare Payment Policy

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality

Apr 01, 2021 / Presentations

Medicare vaccine coverage and payment

Research Areas:

Beneficiaries and Coverage, Drugs, Devices, and Tests, Physicians And Other Health Professionals

Apr 01, 2021 / Presentations

Revising Medicare’s indirect medical education payments to better reflect teaching hospitals’ costs

Research Areas:

Hospitals, Physicians And Other Health Professionals

Mar 30, 2021 / Presentations

Congressional request: Private equity and Medicare

Research Areas:

Hospitals, Physicians And Other Health Professionals, Private Plans

Mar 30, 2021 / Presentations

Improving Medicare’s policies for separately payable drugs in the hospital outpatient prospective payment system

Research Areas:

Beneficiaries and Coverage, Drugs, Devices, and Tests, Hospitals